Investor Alert

New York Markets Close in:

Market Pulse Archives

March 5, 2021, 11:34 a.m. EST

Canada authorizes J&J's COVID-19 vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.32% gained 1.4% in trading on Friday after Canada's health regulatory body said it authorized the company's COVID-19 vaccine. The single-dose vaccine received emergency use authorization in the U.S. on Saturday. J&J's stock has gained 8.7% over the past year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX +0.55% is up 20.4%.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 165.94
-0.54 -0.32%
Volume: 3.12M
April 21, 2021 12:39p
P/E Ratio
29.33
Dividend Yield
2.55%
Market Cap
$438.29 billion
Rev. per Employee
$613,918
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,157.78
+22.84 +0.55%
Volume: 944.93M
April 21, 2021 12:39p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.